Sudeep Pharma Share price

Q: How to buy Sudeep Pharma Share at Choice?

To buy Sudeep Pharma stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sudeep Pharma, choose your preferred order type, and place the trade.

SUDEEPPHRM

Healthcare Mid Cap

754.5

4.10 (-0.54%)

NSE

BSE

Last updated on 5 Jun, 2026 | 15:58 IST

BuySell

Today's High

785.75

Today's Low

742.50

52 Week Low

524.05

52 Week High

816.35

Sudeep Pharma Chart

ChartIQ

TradingView

Sudeep Pharma Share Key Metrics

Volume

1.95 L

Market Cap

8521.97 CR

LTQ@LTP

1@754.50

ATP

760.26 Var Margin

15.8 %

Circuit Range

682.75-834.45

Delivery %

0 %

Value

14.82 CR

ASM/GSM

No

Market Lot

1

Summary

Sudeep Pharma share price is ₹754.5 as of 7 Jun, 2026. The stock Sudeep Pharma intraday movement has stayed between ₹742.50 and ₹785.75, while on a 52-week basis,Sudeep Pharma price 52 week high is ₹816.35 & its 52 week low is ₹524.05.

In terms of trading activity, Sudeep Pharma has recorded a volume of 194981 shares, The Sudeep Pharma has a market cap of ₹112948625 CR. The stock’s Average Traded Price (ATP) stands at ₹760.26, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹754.50.

Sudeep Pharma operates within a circuit range of ₹682.75 – ₹834.45, with a Value of ₹14.82 CR. The Delivery Percentage for the day is 0%. Additionally, Sudeep Pharma currently falls under the No framework, and trades with a market lot size of 1.

Sudeep Pharma Fundamentals

P/E Ratio

49.34

P/B Ratio

9.66

Div. Yield

0

Sector P/E

68.9

Sector P/B

2.97

Sec. Div. Yield

0.54

Sudeep Pharma Resistance and Support

Pivot 763.23

Resistance

First Resistance

772.26

Second Resistance

785.93

Third Resistance

794.96

Support

First Support

749.56

Second Support

740.53

Third Support

726.86

Sudeep Pharma Shareholding Pattern

2026-27
2025-26
2024-25
2023-24

Total Promoters

Segment

Percent

Total Promoters

76.15%

Mutual Fund

5.67%

Insurance

1.06%

Foreign Institutional Investors

1.67%

Domestic Institutional Investors

10.87%

Retail

4.58%

Others

0%

Total Promoters

SEP '25

76.15%

NOV '25

76.15%

DEC '25

76.15%

Sudeep Pharma Corporate Actions

Date	Agenda
2026-05-21	Audited Results
2026-02-06	Quarterly Results
2025-12-19	Quarterly Results

Sudeep Pharma News

Sudeep Pharma Ltd - 544619 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Sudeep Pharma is scheduled to attend two investor conferences. These include the 360 ONE Capital (B&K) 16th Annual Investor Conference - TRINITY INDIA 2026 on May 28, 2026, and the ICICI Securities India Investor Conference - India Rising: The Next Chapter on June 08, 2026.

May 23 2026 09:53:03

Sudeep Pharma Ltd - 544619 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Sudeep Pharma uploaded the audio recording of its Q4 FY26 earnings call, held on May 22, 2026, to its official website. Investors can access the full recording for details on financial performance.

May 22 2026 17:52:00

Sudeep Pharma Limited

Sudeep Pharma Limited's board recommended a final dividend of Rs. 1.5 per equity share for FY 2025-26. The record date for the dividend is July 24, 2026, and payment is proposed by August 9, 2026, post AGM approval.

May 21 2026 17:09:36

Sudeep Pharma Limited

Sudeep Pharma Limited's board recommended a final dividend of Rs. 1.5 per equity share for FY 2025-26. The record date for the dividend is July 24, 2026, and payment is proposed by August 9, 2026, post AGM approval.

May 21 2026 17:08:14

Sudeep Pharma Ltd - 544619 - Board Meeting Outcome for Outcome Of Board Meeting Held On 21St May 2026

Sudeep Pharma board approved FY26 consolidated results with revenue of ₹642.26 cr (up 28% YoY) and net profit of ₹174.28 cr (up 26% YoY). It also recommended a final dividend of ₹1.50 per share for FY26.

May 21 2026 16:05:05

Name	Position
Sujit Jaysukh Bhayani	Chairman & Managing Director
Shanil Sujit Bhayani	Whole Time Director

Sudeep Pharma Similar Stocks

Shilpa Medicare Ltd.

538.05

12.25 (2.33%)

Strides Pharma Science Ltd.

1044.60

17.40 (1.69%)

Healthcare Global Enterprises Ltd.

635.95

-4.00 (0.63%)

Procter & Gamble Health Ltd.

6200.00

-1.00 (0.02%)

Jupiter Life Line Hospitals Ltd.

1307.50

-7.70 (0.59%)

Akums Drugs & Pharmaceuticals Ltd.

553.80

-1.70 (0.31%)

Thyrocare Technologies Ltd.

518.00

-2.75 (0.53%)

Yatharth Hospital & Trauma Care Services Ltd.

808.90

1.20 (0.15%)

Blue Jet Healthcare Ltd.

465.15

-10.45 (2.20%)

Sanofi India Ltd.

3186.40

6.90 (0.22%)

Sudeep Pharma FAQs

The Buying Price of Sudeep Pharma share is 754.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Sudeep Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sudeep Pharma, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Sudeep Pharma shares is 49.34. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Sudeep Pharma shares is 9.66. Useful to assess the stock's value relative to its book value.

To assess Sudeep Pharma’s valuation compare Sector P/E, P/B which are 68.9 & 2.97 with sector averages, along with growth rates and financial metrics.

The Market Cap of Sudeep Pharma is 8521.97 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Sudeep Pharma share price is 816.35 & 524.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Sudeep Pharma belongs to the Healthcare sector.